ZOTA Stock Overview
Develops, manufactures, and markets pharmaceutical products in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Zota Health Care Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹639.65 |
| 52 Week High | ₹645.00 |
| 52 Week Low | ₹372.00 |
| Beta | 0.66 |
| 11 Month Change | 10.57% |
| 3 Month Change | 30.97% |
| 1 Year Change | 58.76% |
| 33 Year Change | 80.54% |
| 5 Year Change | 221.43% |
| Change since IPO | 508.98% |
Recent News & Updates
Is Zota Health Care (NSE:ZOTA) A Risky Investment?
Aug 02
Zota Health Care Limited's (NSE:ZOTA) 29% Jump Shows Its Popularity With Investors
Jun 15Recent updates
Is Zota Health Care (NSE:ZOTA) A Risky Investment?
Aug 02Zota Health Care Limited's (NSE:ZOTA) 29% Jump Shows Its Popularity With Investors
Jun 15Zota Health Care (NSE:ZOTA) Has Re-Affirmed Its Dividend Of ₹1.00
Sep 20Zota Health Care (NSE:ZOTA) Has Announced A Dividend Of ₹1.00
Sep 04Are Dividend Investors Getting More Than They Bargained For With Zota Health Care Limited's (NSE:ZOTA) Dividend?
Mar 25What Type Of Returns Would Zota Health Care's(NSE:ZOTA) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Jan 19
Zota Health Care Limited's (NSE:ZOTA) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
Dec 15Shareholder Returns
| ZOTA | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 10.8% | 3.1% | 2.6% |
| 1Y | 58.8% | 48.9% | 47.8% |
Return vs Industry: ZOTA exceeded the Indian Pharmaceuticals industry which returned 51% over the past year.
Return vs Market: ZOTA exceeded the Indian Market which returned 47.6% over the past year.
Price Volatility
| ZOTA volatility | |
|---|---|
| ZOTA Average Weekly Movement | 5.7% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in IN Market | 9.6% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: ZOTA's share price has been volatile over the past 3 months.
Volatility Over Time: ZOTA's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 338 | Sujit Paul | www.zotahealthcare.com |
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers generic drugs, over-the-counter products, ayurvedic products, and nutraceutical products. The company provides various medicines for chronic illnesses, including diabetes, heart conditions, and thyroid disorders.
Zota Health Care Limited Fundamentals Summary
| ZOTA fundamental statistics | |
|---|---|
| Market cap | ₹16.09b |
| Earnings (TTM) | -₹143.48m |
| Revenue (TTM) | ₹1.80b |
8.9x
P/S Ratio-112.2x
P/E RatioIs ZOTA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZOTA income statement (TTM) | |
|---|---|
| Revenue | ₹1.80b |
| Cost of Revenue | ₹967.00m |
| Gross Profit | ₹837.88m |
| Other Expenses | ₹981.36m |
| Earnings | -₹143.48m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -5.70 |
| Gross Margin | 46.42% |
| Net Profit Margin | -7.95% |
| Debt/Equity Ratio | 16.3% |
How did ZOTA perform over the long term?
See historical performance and comparison